Bupropion Extended-Release Tablets and Daclatasvir Dihydrochloride
Determining the interaction of Bupropion Extended-Release Tablets and Daclatasvir Dihydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bupropion
Brand name: Aplenzin, Buproban, Forfivo XL, Wellbutrin SR, Wellbutrin XL, Zyban, Zyban Advantage Pack, Budeprion XL
Synonyms: Bupropion, BuPROPion
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bupropion Extended-Release Tablets-Daclizumab
- Bupropion Extended-Release Tablets-Daclizumab Subcutaneous
- Bupropion Extended-Release Tablets-Dacogen
- Bupropion Extended-Release Tablets-Dacomitinib
- Bupropion Extended-Release Tablets-Dactinomycin
- Bupropion Extended-Release Tablets-Dactinomycin Injection
- Daclatasvir Dihydrochloride-Bupropion Hydrochloride
- Daclatasvir Dihydrochloride-Bupropion SR Tablets
- Daclatasvir Dihydrochloride-Bupropion Sustained-Release Tablets (Smoking Deterrent)
- Daclatasvir Dihydrochloride-Bupropion Tablets
- Daclatasvir Dihydrochloride-Bupropion Tablets and Sustained-Release Tablets
- Daclatasvir Dihydrochloride-Burapren Injection